Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary and controlled affiliate in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The Company’s most popular product is its Xin Aoxing Oleanolic Acid Capsule, an over-the-counter (“OTC”) medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population.

Bank Name Biostar Pharmaceuticals, Inc.
Stock Exchange NASDAQ
Symbol BSPM
Sector Healthcare
Industry Major Pharmaceuticals
Country United States
World Region America
Chairman Mr. Ronghua Wang
CEO Mr. Ronghua Wang
Employees 200
Registered Year 2007